NeoGenomics Sees FY23 Revenue $585M-$592M Vs $573.19M Est.
Portfolio Pulse from Benzinga Newsdesk
NeoGenomics has projected its FY23 revenue to be between $585M and $592M, which is higher than the estimated $573.19M.
November 06, 2023 | 9:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NeoGenomics has forecasted its FY23 revenue to exceed estimates, which could positively impact its stock price.
NeoGenomics' higher than expected revenue forecast for FY23 indicates strong business performance and growth potential, which could attract investors and drive up its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100